Published in J Am Geriatr Soc on July 01, 2002
Magnitude of underascertainment of impaired kidney function in older adults with normal serum creatinine. J Am Geriatr Soc (2007) 1.85
Renal function assessment in older adults. Br J Clin Pharmacol (2013) 1.19
The applicability of eGFR equations to different populations. Nat Rev Nephrol (2013) 1.10
Recognition and management of chronic kidney disease in an elderly ambulatory population. J Gen Intern Med (2008) 0.90
Is the Chronic Kidney Disease Epidemiology Collaboration creatinine-cystatin C equation useful for glomerular filtration rate estimation in the elderly? Clin Interv Aging (2013) 0.84
Natural history of older adults with impaired kidney function: the InCHIANTI study. Rejuvenation Res (2011) 0.81
Relationship between Systemic and Cerebral Vascular Disease and Brain Structure Integrity in Normal Elderly Individuals. J Alzheimers Dis (2015) 0.80
Cystatin C: a new renal marker and its potential use in small animal medicine. J Vet Intern Med (2014) 0.79
Serum levels of cystatin C in elderly lung cancer patients. Oncol Lett (2011) 0.79
Serum cystatin C may be a better marker of renal impairment than creatinine. J Am Geriatr Soc (2003) 0.77
Evaluation of a new immunoassay for cystatin C, based on a double monoclonal principle, in men with normal and impaired renal function. Nephrol Dial Transplant (2011) 0.77
Renal dysfunction on admission as a predictor for in-hospital mortality of patients with stanford type B acute aortic dissection. Ann Vasc Dis (2013) 0.75
Acute renal failure in patients with sepsis in a surgical ICU: predictive factors, incidence, comorbidity, and outcome. J Am Soc Nephrol (2003) 3.16
Testing for recombinant human erythropoietin. J Appl Physiol (1985) (2008) 3.02
Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta (2006) 2.97
False-positive detection of recombinant human erythropoietin in urine following strenuous physical exercise. Blood (2006) 2.06
Assessment of renal function in recently admitted critically ill patients with normal serum creatinine. Nephrol Dial Transplant (2005) 1.72
Influence of dialysate on gastric emptying time in peritoneal dialysis patients. Perit Dial Int (2002) 1.55
Development of an affordable dye-stained microalbuminuria screening test. Nephrol Dial Transplant (2008) 1.50
Faecal leukocyte esterase activity is an alternative biomarker in inflammatory bowel disease. Clin Chem Lab Med (2015) 1.41
Is folate a promising agent in the prevention and treatment of cardiovascular disease in patients with renal failure? Kidney Int (2002) 1.38
Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane. Kidney Int (2004) 1.26
Effect of nosocomial bloodstream infection on the outcome of critically ill patients with acute renal failure treated with renal replacement therapy. J Am Soc Nephrol (2004) 1.25
Pharmacokinetics of atorvastatin and its metabolites after single and multiple dosing in hypercholesterolaemic haemodialysis patients. Nephrol Dial Transplant (2003) 1.23
Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications. Clin Chim Acta (2008) 1.23
Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies. Nephrol Dial Transplant (2005) 1.18
Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma. Am J Respir Crit Care Med (2010) 1.14
Diagnostic value of the hemopexin N-glycan profile in hepatocellular carcinoma patients. Clin Chem (2010) 1.09
Prohepcidin accumulates in renal insufficiency. Clin Chem Lab Med (2004) 1.09
Alpha 1-microglobulin: clinical laboratory aspects and applications. Clin Chim Acta (2004) 1.08
Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns Study (DOPPS) findings. Am J Kidney Dis (2004) 1.06
Animal models in peritoneal dialysis research: a need for consensus. Perit Dial Int (2005) 1.06
Tumor necrosis factor receptors: biology and therapeutic potential in kidney diseases. Am J Nephrol (2012) 1.05
Increased urinary neutrophil gelatinase associated lipocalin in urinary tract infections and leukocyturia. Clin Chem Lab Med (2011) 1.05
Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model. Kidney Int (2005) 1.05
Analytical interferences in point-of-care testing glucometers by icodextrin and its metabolites: an overview. Perit Dial Int (2009) 1.05
Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int (2008) 1.05
Effects of conventional and new peritoneal dialysis fluids on leukocyte recruitment in the rat peritoneal membrane. J Am Soc Nephrol (2003) 1.01
Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia. Nephrol Dial Transplant (2006) 1.01
Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesothelioma. J Thorac Oncol (2011) 1.00
Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: role of acidity, buffer choice, glucose concentration, and glucose degradation products. J Am Soc Nephrol (2002) 1.00
Sodium bicarbonate versus THAM in ICU patients with mild metabolic acidosis. J Nephrol (2005) 0.97
Effects of connexin-mimetic peptides on nitric oxide synthase- and cyclooxygenase-independent renal vasodilation. Kidney Int (2002) 0.97
Flow cytometry as a new method to quantify the cellular content of human saliva and its relation to gingivitis. Clin Chim Acta (2002) 0.97
A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat. Nephrol Dial Transplant (2005) 0.96
Haptoglobin polymorphism and lacunar stroke. Curr Neurovasc Res (2008) 0.96
Haptoglobin polymorphism and infection. Adv Clin Chem (2010) 0.95
Critical evaluation of connectivity-based point of care testing systems of glucose in a hospital environment. Clin Chem Lab Med (2008) 0.94
Reevaluation of formulas for predicting creatinine clearance in adults and children, using compensated creatinine methods. Clin Chem (2003) 0.94
In vitro study of the potential role of guanidines in leukocyte functions related to atherogenesis and infection. Kidney Int (2004) 0.93
Quantitative evaluation of urinalysis test strips. Clin Chem (2002) 0.92
Inhibition of the interaction of AGE-RAGE prevents hyperglycemia-induced fibrosis of the peritoneal membrane. J Am Soc Nephrol (2003) 0.92
Haptoglobin polymorphism in patients with preeclampsia. Clin Chem Lab Med (2006) 0.92
Glycosylation of prostate specific antigen and its potential diagnostic applications. Clin Chim Acta (2012) 0.91
Endothelium-derived hyperpolarizing factor-mediated renal vasodilatory response is impaired during acute and chronic hyperhomocysteinemia. Circulation (2004) 0.90
Systemic and splanchnic haemodynamic effects of sildenafil in an in vivo animal model of cirrhosis support for a risk in cirrhotic patients. Liver Int (2004) 0.90
No early respiratory benefit with CVVHDF in patients with acute renal failure and acute lung injury. Nephrol Dial Transplant (2002) 0.90
The effect of clinical covariates on the diagnostic and prognostic value of soluble mesothelin and megakaryocyte potentiating factor. Chest (2011) 0.90
Calibration and precision of serum creatinine and plasma cystatin C measurement: impact on the estimation of glomerular filtration rate. J Nephrol (2014) 0.89
Vitamin D binding protein, bone status and body composition in community-dwelling elderly men. Bone (2005) 0.89
A genome-wide association study identifies rs2000999 as a strong genetic determinant of circulating haptoglobin levels. PLoS One (2012) 0.89
Non-oxidative ethanol metabolites as a measure of alcohol intake. Clin Chim Acta (2012) 0.89
Biological and clinical aspects of soluble transferrin receptor. Crit Rev Clin Lab Sci (2010) 0.88
Glycated nail proteins: a new approach for detecting diabetes in developing countries. Trop Med Int Health (2013) 0.88
Biologically active, magnICON®-expressed EPO-Fc from stably transformed Nicotiana benthamiana plants presenting tetra-antennary N-glycan structures. J Biotechnol (2012) 0.87
Serum free hemoglobin concentrations in healthy individuals are related to haptoglobin type. Clin Chem (2005) 0.86
The effects of peritoneal dialysis solutions on peritoneal host defense. Perit Dial Int (2004) 0.86
Serial measurements of mesothelioma serum biomarkers in asbestos-exposed individuals: a prospective longitudinal cohort study. J Thorac Oncol (2011) 0.86
Vitamin D binding protein: a multifunctional protein of clinical importance. Adv Clin Chem (2014) 0.86
Vitamin D binding protein, a new nutritional marker in cystic fibrosis patients. Clin Chem Lab Med (2008) 0.85
Serum vitamin C concentration is influenced by haptoglobin polymorphism and iron status in Chinese. Clin Chim Acta (2005) 0.85
Studies on dialysate mixing in the Genius single-pass batch system for hemodialysis therapy. Kidney Int (2003) 0.85
Urinary beta-trace protein as a new renal tubular marker. Clin Chem (2009) 0.84
Evaluation of Sysmex UF-1000i for use in cerebrospinal fluid analysis. Clin Chim Acta (2008) 0.83
Pathophysiological role of vascular endothelial growth factor in the remnant kidney. Nephron Exp Nephrol (2005) 0.83
Automated flow cytometry analysis of peritoneal dialysis fluid. Nephrol Dial Transplant (2004) 0.83
Haptoglobin phenotype correlates with the extent of cerebral deep white matter lesions in hypertensive patients. Curr Neurovasc Res (2010) 0.83
Creatine supplementation decreases homocysteine in an animal model of uremia. Kidney Int (2003) 0.82
Chemiluminescent image detection of haptoglobin phenotyping after polyacrylamide gel electrophoresis. Anal Chem (2004) 0.82
Determination of beta2-agonists by ion chromatography with direct conductivity detection. J Pharm Biomed Anal (2005) 0.81
Glomerular filtration rate is a confounder for the measurement of soluble mesothelin in serum. Clin Chem (2009) 0.81
Proteolysis is a confounding factor in the interpretation of faecal calprotectin. Clin Chem Lab Med (2015) 0.81
Guanidino compounds after creatine supplementation in renal failure patients and their relation to inflammatory status. Nephrol Dial Transplant (2007) 0.81
Value and pitfalls in iodine fortification and supplementation in the 21st century. Br J Nutr (2011) 0.80
The effects of heparin administration in an animal model of chronic peritoneal dialysate exposure. Perit Dial Int (2002) 0.80
Investigation of the potential association of vitamin D binding protein with lipoproteins. Ann Clin Biochem (2010) 0.80
Java project on periodontal diseases: periodontal bone loss in relation to environmental and systemic conditions. J Clin Periodontol (2015) 0.80
Human epididymis protein 4 in cancer diagnostics: a promising and reliable tumor marker. Adv Clin Chem (2013) 0.80
Soluble transferrin receptor in urine, a new biomarker for IgA nephropathy and Henoch-Schönlein purpura nephritis. Clin Biochem (2013) 0.79
Unanswered questions in including HDL-cholesterol in the cardiovascular risk estimation. Is time still on our side? Atherosclerosis (2012) 0.79
Health implications of antimicrobial resistance for patients with acute kidney injury and bloodstream infection. Infect Control Hosp Epidemiol (2007) 0.79
Biology of human pentraxin 3 (PTX3) in acute and chronic kidney disease. J Clin Immunol (2013) 0.79
Long-term renal changes in the Goto-Kakizaki rat, a model of lean type 2 diabetes. Nephrol Dial Transplant (2004) 0.79
Compensating for the influence of total serum protein in the Schwartz formula. Clin Chem Lab Med (2012) 0.78
Galectin-3 in Renal Pathology: More Than Just an Innocent Bystander. Am J Nephrol (2016) 0.78
Vascular hyporesponsiveness in the mesenteric artery of anaesthetized rats with cirrhosis and portal hypertension: an in-vivo study. Eur J Gastroenterol Hepatol (2004) 0.78
Chronic nicotine exposure and acute kidney injury: new concepts and experimental evidence. Nephrol Dial Transplant (2013) 0.78
Carbohydrate deficient transferrin in a driver's license regranting program. Alcohol Alcohol (2012) 0.78
Folates from metabolically engineered rice: a long-term study in rats. Mol Nutr Food Res (2015) 0.78
Creatine supplementation does not decrease total plasma homocysteine in chronic hemodialysis patients. Kidney Int (2004) 0.78
Use of nanomaterials in capillary and microchip electrophoresis. Expert Rev Proteomics (2007) 0.78
Iron status in black persons is not influenced by haptoglobin polymorphism. Clin Chem Lab Med (2002) 0.78
Direct chemiluminescent imaging detection of human serum proteins in two-dimensional polyacrylamide gel electrophoresis. Proteomics (2007) 0.77
Antibiotic administration in an animal model of chronic peritoneal dialysate exposure. Perit Dial Int (2003) 0.77
The haptoglobin phenotype is associated with the Epstein-Barr virus antibody titer. Clin Chem Lab Med (2009) 0.77
Spuriously high thyrotropin values due to anti-thyrotropin antibodies in adult patients. Clin Chem Lab Med (2009) 0.77
Creatine supplementation does not affect kidney function in an animal model with pre-existing renal failure. Nephrol Dial Transplant (2003) 0.77